Working... Menu

SFX-01 in the Treatment and Evaluation of Metastatic Breast Cancer (STEM)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT02970682
Recruitment Status : Active, not recruiting
First Posted : November 22, 2016
Last Update Posted : August 2, 2018
Premier Research Group plc
Information provided by (Responsible Party):
Evgen Pharma

No Study Results Posted on for this Study
  Recruitment Status : Active, not recruiting
  Estimated Primary Completion Date : January 2019
  Estimated Study Completion Date : March 2019